keyboard_arrow_up

Hungary Pharmaceuticals and Healthcare Market Research Report Q2 2015

Summary:

Hungary‚Äôs pharmaceutical market will stabilise and grow slightly in 2015. The challenging operating environment, regulatory burden and punitive taxes on the pharmaceutical sector will continue to stunt growth. Pharmaceutical growth in local currency terms will be driven by consumer demand for over the-counter medicines and greater uptake of generic medicines.

Headline Expenditure Projections:

  • Pharmaceuticals: HUF579.14bn (USD2.50bn) in 2014 to HUF590.49bn (USD2.31bn) in 2014; +2.0% in local currency terms and -7.9% in US dollar terms.
  • Healthcare: HUF2,191bn (USD9.47bn) in 2014 to HUF2,232bn (USD8.72bn) in 2014; +1.9% in local currency terms and -7.9% in US dollar terms.

Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=287679 .

Table of Contents

Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2011-2019) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019) 21
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019) 23
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019) 25
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Top 10 Import Partners For Pharmaceutical Goods (2013) 28
Table: Top 10 Export Partners For Pharmaceuticals 29
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2013-2019) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2013-2019) 30
Key Risks To BMI's Forecast Scenario 30
Macroeconomic Forecasts 32
Economic Analysis 32
Table: GDP By Expenditure (Hungary 2011-2018) 38
Industry Risk Reward Ratings 39
Central And Eastern Europe Risk/Reward Index 39
Hungary Risk/Reward Index 45
Rewards 45
Risks 45
Market Overview 47
Industry Trends And Developments 49
Epidemiology 49
Healthcare System 52
Healthcare Funding 53
Research and Development (R&D) 54
Clinical Trials 55
Regulatory Development 56
Pharmaceutical Advertising 57
Intellectual Property Regime 58
Pricing Regime 60
Table: OEP Reimbursement Changes, September 2014 62
Pharmaceutical Mark-Ups 62
Table: Hungary - Pharmaceutical Price Build-Up (%) 62
Reimbursement Regime 62
Hospital Procurement 65
Competitive Landscape 66
Company Profile 71
Gedeon Richter 71
Egis Pharmaceuticals (Servier) 75
Pfizer 79
Novartis 82
Sanofi 84
GlaxoSmithKline 86
Merck & Co 88
Eli Lilly 90
Teva 92
Demographic Forecast 95
Table: Population Headline Indicators (Hungary 1990-2025) 96
Table: Key Population Ratios (Hungary 1990-2025) 96
Table: Urban/Rural Population And Life Expectancy (Hungary 1990-2025) 97
Table: Population By Age Group (Hungary 1990-2025) 97
Table: Population By Age Group % (Hungary 1990-2025) 98
Glossary 100
Methodology 102
Pharmaceutical Expenditure Forecast Model 102
Healthcare Expenditure Forecast Model 102
Notes On Methodology 103
Risk/Reward Index Methodology 104
Index Overview 105
Table: Pharmaceutical Risk/Reward Index Indicators 105
Indicator Weightings 106

List of Tables

Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2011-2019)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 2011-2019)
Table: Top 10 Import Partners For Pharmaceutical Goods (2013)
Table: Top 10 Export Partners For Pharmaceuticals
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2013-2019)
Table: GDP By Expenditure (Hungary 2011-2018)
Table: OEP Reimbursement Changes, September 2014
Table: Hungary - Pharmaceutical Price Build-Up (%)
Table: Population Headline Indicators (Hungary 1990-2025)
Table: Key Population Ratios (Hungary 1990-2025)
Table: Urban/Rural Population And Life Expectancy (Hungary 1990-2025)
Table: Population By Age Group (Hungary 1990-2025)
Table: Population By Age Group % (Hungary 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators

Complete Report is Available @ http://www.rnrmarketresearch.com/hungary-pharmaceuticals-and-healthcare-report-q2-2015-market-report.html .